Health Condition 1: F988- Other specified behavioral and emotional disorders with onset usually occurring in childhood and adolescence
Conditions
Interventions
Intervention1: L-Carnosine: L-Carnosine(10-15mg/kg) along with standard care(occupational and speech therapy)
Intervention2: Pyridoxine-Magnesium sulphate: 20mg Pyridoxine hydrochloride and 40mg Magne
Sponsors
Brio Bliss Life Science Pvt Ltd
Eligibility
Inclusion criteria
Inclusion criteria: children between the ages of 3 and 6 years who were having mild to moderate ASD diagnosed using Childhood Autism Rating Scale, Second Edition-Standard Version(CARS2-ST) and INCLEN Diagnostic tool for Autism Spectrum Disorder.
Exclusion criteria
Exclusion criteria: children undergoing any chronic drug treatment, severe intellectual disability, history of seizure, presence of hepatic disease, having any other genetic and chromosomal syndromes as well as children with chronic illness or known hormonal and metabolic diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the effect of L-carnosine and pyridoxine-magnesium sulphate in children with ASDTimepoint: 0,2 months | — |
Secondary
| Measure | Time frame |
|---|---|
| practice, perception of complementary and alternative medicine use among parents of ASD childrenTimepoint: 0 | — |
Countries
India
Contacts
Public ContactDr M G Rajanandh
Sri Ramachandra Institute of Higher Education and Research
Outcome results
None listed